Form4insider filings, from the source

SEC Form 4 · accession 0001093557-16-000699

DEXCOM INC · DXCM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jay S Skyler
Director
Period of report
Sep 9, 2016
Accepted (ET)
Sep 13, 2016 · 8:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Sep 9, 2016S25,000$94.0715D17,246Iby Partnership
Common Stockholding———5,011D
Common StockF3holding———10,000Iby Daughter
Common StockF4holding———10,000Iby Spouse

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

CONFIRMING STATEMENT: This Statement confirms that the undersigned Jay S. Skyler, M.D., has authorized and designated Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien to execute and file on the undersigned's behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of DexCom, Inc. The authority of Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4, and 5 with regard to the undersigned's ownership of or transactions in securities of DexCom, Inc., unless earlier revoked in writing. The undersigned acknowledges that Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien are not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. Date: September 8, 2016 /s/ JAY S. SKYLER Jay S. Skyler